Product Overview

GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide renowned in the field of endocrinology for its potent secretagogue properties. As a first-generation Growth Hormone Secretagogue (GHS), it acts as a high-affinity agonist of the GHSR-1a (Ghrelin) receptor.

While chemically related to GHRP-6, GHRP-2 is precision-engineered to provide a more robust release of endogenous Growth Hormone (GH) with a significantly reduced impact on gastric motility and appetite stimulation at standard research concentrations.

Advanced Mechanism of Action

GHRP-2 utilizes a multi-pathway approach to modulate the endocrine system, mimicking the physiological role of endogenous ghrelin:

• Pituitary Activation: It binds directly to receptors on the somatotroph cells in the anterior pituitary, triggering an immediate release of GH.

• Hypothalamic Amplification: It enhances the signaling of GHRH (Growth Hormone-Releasing Hormone) while simultaneously inhibiting Somatostatin (the “Growth Hormone-Inhibiting Hormone”).

• Synergistic Potential: Due to its unique action on somatostatin suppression, it is frequently studied in conjunction with GHRH analogues to observe synergistic GH “pulses.”

Chemical & Physical Specifications

Handling and Stability

To maintain the structural integrity of the hexapeptide chain, follow these standardized storage protocols:

• Short-Term Storage: 2°C to 8°C (Refrigerated).

• Long-Term Storage: -20°C (Frozen) to prevent peptide degradation.

• Reconstitution: Must be reconstituted with Bacteriostatic Water or Sterile Saline prior to laboratory application.

Research Disclaimer

ATTENTION: This compound is strictly intended for Laboratory Research and Analytical Use Only. It is not approved for human or veterinary consumption, medical diagnosis, or therapeutic application. The purchase of this product constitutes an agreement that it will be handled by qualified professionals within a controlled research environment.